LOM
VRTX icon

Loeb Offshore Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Loeb Offshore Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-5,302
Closed -$394K – 216
2013
Q4 		$394K Buy
5,302
+1,619
+44% +$113K 0.11% 138
2013
Q3 		$279K Buy
+3,683
New +$293K 0.09% 163

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Loeb Offshore Management's VRTX Position: Q1 2014 in Review

Loeb Offshore Management sold out of Vertex Pharmaceuticals (VRTX) in Q1 2014, closing a stake of 5,302 shares — an estimated $394K sold.

Loeb Offshore Management first reported a position in VRTX in Q3 2013 and held it in 2 quarters. The position peaked at $394K in Q4 2013. 395 funds tracked by Wall St. Rank hold VRTX as of Q1 2014.

  • Loeb Offshore Management reported no remaining Vertex Pharmaceuticals position as of Q1 2014 after selling out during the quarter.
  • Loeb Offshore Management sold 5,302 Vertex Pharmaceuticals shares in Q1 2014, an estimated $394K.
  • Loeb Offshore Management first reported a position in Vertex Pharmaceuticals in Q3 2013 and held it in 2 quarters.
  • Loeb Offshore Management's Vertex Pharmaceuticals position peaked at $394K in Q4 2013.
  • 395 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2014.

Based on Loeb Offshore Management's 13F filing for Q1 2014, filed 15 May 2014.